173 related articles for article (PubMed ID: 34067074)
1. Interleukin-32θ Triggers Cellular Senescence and Reduces Sensitivity to Doxorubicin-Mediated Cytotoxicity in MDA-MB-231 Cells.
Pham TH; Park HM; Kim J; Hong JT; Yoon DY
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34067074
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-32θ inhibits tumor-promoting effects of macrophage-secreted CCL18 in breast cancer.
Pham TH; Bak Y; Kwon T; Kwon SB; Oh JW; Park JH; Choi YK; Hong JT; Yoon DY
Cell Commun Signal; 2019 May; 17(1):53. PubMed ID: 31126309
[TBL] [Abstract][Full Text] [Related]
3. Ginsenoside Rh2 Ameliorates Doxorubicin-Induced Senescence Bystander Effect in Breast Carcinoma Cell MDA-MB-231 and Normal Epithelial Cell MCF-10A.
Hou JG; Jeon BM; Yun YJ; Cui CH; Kim SC
Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30871042
[TBL] [Abstract][Full Text] [Related]
4. Modulatory effects of point-mutated IL-32θ (A94V) on tumor progression in triple-negative breast cancer cells.
Park HM; Park JY; Kim NY; Kim J; Pham TH; Hong JT; Yoon DY
Biofactors; 2024; 50(2):294-310. PubMed ID: 37658685
[TBL] [Abstract][Full Text] [Related]
5. A novel indenone derivative selectively induces senescence in MDA-MB-231 (breast adenocarcinoma) cells.
Priyanga J; Sharan Kumar B; Mahalakshmi R; Nirekshana K; Vinoth P; Sridharan V; Bhakta-Guha D; Guha G
Chem Biol Interact; 2020 Nov; 331():109250. PubMed ID: 32956706
[TBL] [Abstract][Full Text] [Related]
6. Different sensitivities of senescent breast cancer cells to immune cell-mediated cytotoxicity.
Inao T; Kotani H; Iida Y; Kartika ID; Okimoto T; Tanino R; Shiba E; Harada M
Cancer Sci; 2019 Sep; 110(9):2690-2699. PubMed ID: 31250942
[TBL] [Abstract][Full Text] [Related]
7. Improved Autophagic Flux in Escapers from Doxorubicin-Induced Senescence/Polyploidy of Breast Cancer Cells.
Bojko A; Staniak K; Czarnecka-Herok J; Sunderland P; Dudkowska M; Śliwińska MA; Salmina K; Sikora E
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32846959
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of osteopontin expression by RNA interference affects cell proliferation and chemotherapy sensitivity of breast cancer MDA-MB-231 cells.
Yang L; Wei L; Zhao W; Wang X; Zheng G; Zheng M; Song X; Zuo W
Mol Med Rep; 2012 Feb; 5(2):373-6. PubMed ID: 22143930
[TBL] [Abstract][Full Text] [Related]
9. Growth factors and chemotherapeutic modulation of breast cancer cells.
Ciftci K; Su J; Trovitch PB
J Pharm Pharmacol; 2003 Aug; 55(8):1135-41. PubMed ID: 12956904
[TBL] [Abstract][Full Text] [Related]
10. Sulforaphane induces autophagy by inhibition of HDAC6-mediated PTEN activation in triple negative breast cancer cells.
Yang F; Wang F; Liu Y; Wang S; Li X; Huang Y; Xia Y; Cao C
Life Sci; 2018 Nov; 213():149-157. PubMed ID: 30352240
[TBL] [Abstract][Full Text] [Related]
11. Senescence-associated IL-6 and IL-8 cytokines induce a self- and cross-reinforced senescence/inflammatory milieu strengthening tumorigenic capabilities in the MCF-7 breast cancer cell line.
Ortiz-Montero P; Londoño-Vallejo A; Vernot JP
Cell Commun Signal; 2017 May; 15(1):17. PubMed ID: 28472950
[TBL] [Abstract][Full Text] [Related]
12. Conditioned medium from stimulated macrophages inhibits growth but induces an inflammatory phenotype in breast cancer cells.
Song W; Thakor P; Vesey DA; Gobe GC; Morais C
Biomed Pharmacother; 2018 Oct; 106():247-254. PubMed ID: 29966967
[TBL] [Abstract][Full Text] [Related]
13. A Second-Generation Proteasome Inhibitor and Doxorubicin Modulates IL-6, pSTAT-3 and NF-kB Activity in MDA-MB-231 Breast Cancer Cells.
Vyas D; Lopez-Hisijos N; Shah P; Deshpande KS; Basson MD; Vyas A; Chaturvedi LS
J Nanosci Nanotechnol; 2017 Jan; 17(1):175-85. PubMed ID: 29617099
[TBL] [Abstract][Full Text] [Related]
14. IL-32θ inhibits monocytic differentiation of leukemia cells by attenuating expression of transcription factor PU.1.
Kim MS; Kang JW; Park YS; Lee DH; Bak Y; Kwon T; Yoon DY
Oncotarget; 2015 Feb; 6(6):4394-405. PubMed ID: 25726525
[TBL] [Abstract][Full Text] [Related]
15. The novel camptothecin derivative, CPT211, induces cell cycle arrest and apoptosis in models of human breast cancer.
Chiu CF; Lin YQ; Park JM; Chen YC; Hung SW; Chiu CC; Chang CF
Biomed Pharmacother; 2020 Aug; 128():110309. PubMed ID: 32505820
[TBL] [Abstract][Full Text] [Related]
16. IL-32θ inhibits stemness and epithelial-mesenchymal transition of cancer stem cells via the STAT3 pathway in colon cancer.
Bak Y; Kwon T; Bak IS; Hong J; Yu DY; Yoon DY
Oncotarget; 2016 Feb; 7(6):7307-17. PubMed ID: 26824417
[TBL] [Abstract][Full Text] [Related]
17. Insulin like growth factor binding protein-7 reduces growth of human breast cancer cells and xenografted tumors.
Amemiya Y; Yang W; Benatar T; Nofech-Mozes S; Yee A; Kahn H; Holloway C; Seth A
Breast Cancer Res Treat; 2011 Apr; 126(2):373-84. PubMed ID: 20464481
[TBL] [Abstract][Full Text] [Related]
18. The effect of
Asadi-Samani M; Rafieian-Kopaei M; Lorigooini Z; Shirzad H
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30459240
[TBL] [Abstract][Full Text] [Related]
19. C
Chang WT; Wu CY; Lin YC; Wu MT; Su KL; Yuan SS; Wang HD; Fong Y; Lin YH; Chiu CC
Int J Mol Sci; 2019 Sep; 20(17):. PubMed ID: 31480728
[TBL] [Abstract][Full Text] [Related]
20. The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells.
Li JP; Yang YX; Liu QL; Pan ST; He ZX; Zhang X; Yang T; Chen XW; Wang D; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1627-52. PubMed ID: 25834401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
